PLoS Neglected Tropical Diseases (Nov 2018)

Antibody responses to Zika virus proteins in pregnant and non-pregnant macaques.

  • Anna S Heffron,
  • Emma L Mohr,
  • David Baker,
  • Amelia K Haj,
  • Connor R Buechler,
  • Adam Bailey,
  • Dawn M Dudley,
  • Christina M Newman,
  • Mariel S Mohns,
  • Michelle Koenig,
  • Meghan E Breitbach,
  • Mustafa Rasheed,
  • Laurel M Stewart,
  • Jens Eickhoff,
  • Richard S Pinapati,
  • Erica Beckman,
  • Hanying Li,
  • Jigar Patel,
  • John C Tan,
  • David H O'Connor

DOI
https://doi.org/10.1371/journal.pntd.0006903
Journal volume & issue
Vol. 12, no. 11
p. e0006903

Abstract

Read online

The specificity of the antibody response against Zika virus (ZIKV) is not well-characterized. This is due, in part, to the antigenic similarity between ZIKV and closely related dengue virus (DENV) serotypes. Since these and other similar viruses co-circulate, are spread by the same mosquito species, and can cause similar acute clinical syndromes, it is difficult to disentangle ZIKV-specific antibody responses from responses to closely-related arboviruses in humans. Here we use high-density peptide microarrays to profile anti-ZIKV antibody reactivity in pregnant and non-pregnant macaque monkeys with known exposure histories and compare these results to reactivity following DENV infection. We also compare cross-reactive binding of ZIKV-immune sera to the full proteomes of 28 arboviruses. We independently confirm a purported ZIKV-specific IgG antibody response targeting ZIKV nonstructural protein 2B (NS2B) that was recently reported in ZIKV-infected people and we show that antibody reactivity in pregnant animals can be detected as late as 127 days post-infection (dpi). However, we also show that these responses wane over time, sometimes rapidly, and in one case the response was elicited following DENV infection in a previously ZIKV-exposed animal. These results suggest epidemiologic studies assessing seroprevalence of ZIKV immunity using linear epitope-based strategies will remain challenging to interpret due to susceptibility to false positive results. However, the method used here demonstrates the potential for rapid profiling of proteome-wide antibody responses to a myriad of neglected diseases simultaneously and may be especially useful for distinguishing antibody reactivity among closely related pathogens.